Cargando…
Highly portable quantitative screening test for prostate-specific antigen at point of care
Prostate cancer (PCa) is the second most diagnosed cancer among men. Targeted PCa screening may decrease PCa-specific mortality. Prostate-specific antigen (PSA) is the most reliable and widely accepted tumor biomarker for screening and monitoring PCa status. However, in many settings, quantification...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789004/ https://www.ncbi.nlm.nih.gov/pubmed/35083431 http://dx.doi.org/10.1016/j.crbiot.2021.11.003 |